Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qianwen Xu
Observed names:
Q W Xu,
Qian-Wen Xu,
Qian-wen Xu
Institution:
Anhui University of Traditional Chinese Medicine
Observed institutions:
University of Science and Technology of China,
Shandong University,
Anhui Medical University,
Anhui University of Traditional Chinese Medicine,
Anhui Provincial Hospital
ORCID:
0000-0002-6198-0829
Observed ORCID:
0000-0002-6198-0829
OpenAlex ID:
A5003032233
Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients with hematologic malignancy
2021
·
Lei Xue
, Yan Yi
, et al.
·
Cell Discovery
·
61
PDF
IL-10 Expressing CD19 CAR-T Cells Induce Complete Remission and Improve Long-Term Protection in Relapsed or Refractory B-Cell Hematological Malignancies
2024
·
Yugang Guo
, Qianwen Xu
, et al.
·
Blood
·
13
Research progress in the use of botulinum toxin type a for post-stroke spasticity rehabilitation: a narrative review
2025
·
Qianwen Xu
, Hongbo Xiao
, et al.
·
Annals of Medicine
·
11
PDF
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
2025
·
Qianwen Xu
, Yugang Guo
, et al.
·
The Lancet Haematology
·
8
CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation
2021
·
Qianwen Xu
, Hui Xu
, et al.
·
Chinese Medical Journal
·
7
In vitro and in vivo activity of sodium houttuyfonate and sodium new houttuyfonate against Candida auris infection by affecting adhesion, aggregation, and biofilm formation abilities
2025
·
Guangyuan Yang
, Ruotong Yang
, et al.
·
Microbiology Spectrum
·
5
Mitochondrial anchor protein Num11 is key to pathogenicity of Candida albicans by affecting mitochondrial function and cell wall masking
2025
·
Guangyuan Yang
, Xiaojia Niu
, et al.
·
Virulence
·
4
PDF
Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study
2023
·
Zhenkai Luo
, Binbin Jiao
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy
2023
·
Qianwen Xu
, Yi Shi
, et al.
·
Cell Transplantation
·
3
Abstract LB236: Metabolically armed CD19 CAR-T cells for safe and effective treatment of relapsed or refractory CD19+ B cell hematological malignancies at extremely low doses
2024
·
Yugang Guo
, Qianwen Xu
, et al.
·
Cancer Research
·
2
Longitudinal Serum Proteomics Characterization of CD19-CAR-T Cell Therapy for B-Cell Malignancies
2023
·
Youming Wang
, Rui Sun
, et al.
·
Journal of Proteome Research
·
2
Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies
2022
·
Qian-wen Xu
, Hui Xu
, et al.
·
Transfusion and Apheresis Science
·
2
Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells
2022
·
Qianwen Xu
, Lei Xue
, et al.
·
Frontiers in Immunology
·
2
PDF
The Role of Mitochondrial Protein UPS1 in Regulating Pathogenicity of Candida albicans
2026
·
Qianwen Xu
, Changlong Xie
, et al.
·
Journal of Fungi
·
1
[Effect of Chidamide on the Killing Acitivity of NK Cells Targeting K562 Cells and Its Related Mechanism In Vitro].
2020
·
Liang-Yin Weng
, Lei Xue
, et al.
·
PubMed
·
1
CT-244 Updated Clinical Progress of IL-10 expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses
2024
·
Yugang Guo
, Qianwen Xu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Updated Clinical Progress of IL-10-Expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses
2024
·
Yugang Guo
, Qianwen Xu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Updated Clinical Progress of IL-10 expressing CD19 CAR-T Cells for Treatment of Relapsed or Refractory B-Cell Hematological Malignancies at Tiny Doses
2024
·
Yugang Guo
, Qianwen Xu
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
[CAR-T cell therapy for mixed phenotype acute leukemia: a case report].
2020
·
C X He
, L Xue
, et al.
·
PubMed Central
PDF
Show more works
View as search
Works count:
19
Citation count:
126
H-index:
5
I10-index:
3
Year
Topic
Type